Kaitlyn Hevner expects to complete a 15-month accelerated nursing program at the University of North Florida in Jacksonville in December.…
Home »
GSK Announces FDA Approval for Nucala (mepolizumab) for use in Adults with Chronic Rhinosinusitis with Nasal Polyps
29 July 2021 — GlaxoSmithKline plc (GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala…
Analysis: Necessary or Not, Covid Booster Shots Are Probably on the Horizon
The drugmaker Pfizer recently announced that vaccinated people are likely to need a booster shot to be effectively protected against…
FDA Approves Fexinidazole as the First All-Oral Treatment for Sleeping Sickness
July 19, 2021 — The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for…
Biden’s July Executive Order Includes Drug Pricing Provisions. But Will They Do Enough?
President Joe Biden’s executive order of July 9 included various steps toward making good on campaign promises to take on…
Biden Quietly Transforms Medicaid Safety Net
The Biden administration is quietly engineering a series of expansions to Medicaid that may bolster protections for millions of low-income…
FDA Weighs Approval of a Lucrative Alzheimer’s Drug but Benefits Are Iffy
The Food and Drug Administration’s decision next week whether to approve the first treatment for Alzheimer’s disease highlights a deep…
This Small Canadian Drugmaker Wants to Make J&J Vaccines for Poor Nations. It Needs More Than a Patent Waiver.
Biolyse Pharma Corp., which makes a cancer medication, was gearing up to start making generic biologic drugs, made from living…
Cuatro respuestas sobre el freno a la vacuna contra covid de Johnson & Johnson
Cuatro meses después del lanzamiento del plan de inmunización masiva más grande del país en décadas, ha quedado claro que…
FDA Approves Sarclisa (isatuximab-irfc) in Combination with Carfilzomib and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with…